NIH Accelerating Medicines Partnership has awarded 10 US centers grants to study Rheumatoid Arthritis and Lupus

In September 2014, the participating members of the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus (AMP RA/Lupus) Program funded a research Network to implement the program. The Network comprises a Leadership Center and several research sites that will work collaboratively to define shared and disease-specific biological pathways in order to identify relevant drug targets for the treatment of RA, lupus, and related autoimmune diseases.

Continue Reading
Overview of the Accelerating Medicines Partnership (AMP) Rheumatoid Arthritis and Lupus Network

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright {{ 'now'|date('Y') }} All Rights Reserved.